Back to the Future: Therapeutic Targeting of Cancer Cell Metabolism.
1 Discovery Oncology Research, Lilly Research Laboratories, Indianapolis, IN, USA.
Raymond
R
Gilmour
2 Cell Signaling Therapies, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.
Susana
S
Velasco
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D015972:Gene Expression Regulation, Neoplastic; D005947:Glucose / Q000378:metabolism; D005973:Glutamine / Q000378:metabolism; D006019:Glycolysis / Q000235:genetics*; D006801:Humans; D058990:Molecular Targeted Therapy / Q000379:methods; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D009857:Oncogenes; D010085:Oxidative Phosphorylation; D012694:Serine / Q000378:metabolism
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D009363:Neoplasm Proteins; D005973:Glutamine; D012694:Serine; D005947:Glucose